↓ Skip to main content

Disparities in US Healthcare Provider Screening and Advice for Cessation Across Chronic Medical Conditions and Tobacco Products

Overview of attention for article published in Journal of General Internal Medicine, May 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
114 Mendeley
Title
Disparities in US Healthcare Provider Screening and Advice for Cessation Across Chronic Medical Conditions and Tobacco Products
Published in
Journal of General Internal Medicine, May 2017
DOI 10.1007/s11606-017-4062-6
Pubmed ID
Authors

Diana R. Keith, Cassandra A. Stanton, Diann E. Gaalema, Janice Y. Bunn, Nathan J. Doogan, Ryan Redner, Allison N. Kurti, Antonio Cepeda-Benito, Alexa A. Lopez, Adam L. Morehead, Megan E. Roberts, Stephen T. Higgins

Abstract

Disparities in tobacco use are worsening in the United States, disproportionately affecting those with chronic medical conditions. One possible contributor is that physicians may not screen and advise cessation uniformly across patients and/or tobacco products. This study examined provider communications regarding cigarette and non-cigarette tobacco products among adults with chronic conditions. Cross-sectional study drawn from two waves (2013-2014) of the National Survey on Drug Use and Health (NSDUH). Adults (≥ 18 years) who used tobacco in the past year. Prevalence of tobacco use included past-year use of cigarettes, cigars, or smokeless tobacco among those with and without chronic conditions. Chronic conditions included asthma, anxiety, coronary heart disease, depression, diabetes, hepatitis, HIV, hypertension, lung cancer, stroke, and substance abuse. Odds ratio of receipt of screening and advice to quit across chronic condition and tobacco product type were reported. Data were analyzed using logistic regression, controlling for basic sociodemographic factors and number of provider visits. Adults with anxiety, depression, and substance use disorders had the highest prevalence of past-year cigarette (37.2-58.2%), cigar (9.1-28.0%), and smokeless tobacco (3.1-11.7%) use. Patients with any chronic condition were more likely to receive advice to quit than those without a condition (OR 1.21-2.37, p < 0.01), although the odds were lowest among adults with mental health and substance use disorders (OR 1.21-1.35, p < 0.01). Cigarette smokers were more likely to report being screened and advised to quit than non-cigarette tobacco users (OR 1.54-5.71, p < 0.01). Results support the need for provider training to expand screening and cessation interventions to include the growing spectrum of tobacco products. Screening and referral to interventions are especially needed for those with mental health and substance use disorders to reduce the disparate burden of tobacco-related disease and death.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 114 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 14%
Researcher 14 12%
Student > Ph. D. Student 11 10%
Student > Doctoral Student 8 7%
Student > Bachelor 5 4%
Other 22 19%
Unknown 38 33%
Readers by discipline Count As %
Medicine and Dentistry 21 18%
Psychology 15 13%
Nursing and Health Professions 12 11%
Social Sciences 7 6%
Neuroscience 2 2%
Other 13 11%
Unknown 44 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2017.
All research outputs
#14,759,948
of 23,911,072 outputs
Outputs from Journal of General Internal Medicine
#5,426
of 7,806 outputs
Outputs of similar age
#170,853
of 313,948 outputs
Outputs of similar age from Journal of General Internal Medicine
#30
of 55 outputs
Altmetric has tracked 23,911,072 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,806 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,948 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.